CLINICAL_TRIALS
trial_result
· 2014-02-19
Clinical Trial Update: Study Assessing Dolutegravir in HIV-1 Infected Subjects With Virus Resistant to Raltegravir and/or Elivitegravir [Phase 3]
Summary
Phase 3 trial evaluating dolutegravir in HIV-1 infected subjects with resistance to raltegravir and/or elvitegravir; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2014-02-19